HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tainted Peanut Lessons Remain For Food Industry – Attorney

This article was originally published in The Tan Sheet

Executive Summary

Recalls linked to 2009 distribution of PCA’s tainted products made more firms focus on supplier verification and improving supply chain security, but Sunland’s problems in 2012 illustrated more needs to be done, says lawyer Sarah Brew.

You may also be interested in...



PCA Indictments Send Warnings On Vendor Qualification, Responsibility

The Justice Department’s decision to indict four former officials of Peanut Corporation of America for distributing and covering up information related to tainted peanuts illustrates the need for supplement makers to qualify their vendors, industry leaders say.

FDA Suspension Authority Limits Peanut Recall, But FSMA Remains Grounded

In a series of interviews, food safety experts weigh in on why the food and nutritional products industry still has work to do with the Food Safety Modernization Act not yet implemented, as illustrated by the recent salmonella contamination of peanut ingredients from Sunland Inc.

House Adds Food Safety To Appropriations Bill To Resolve Procedural Glitch

House Democrats move to resolve a constitutional glitch holding up a food safety reform bill by adding the legislation to a comprehensive appropriations bill.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel